...
首页> 外文期刊>Human gene therapy methods. >Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine Hepatocytes In Vivo
【24h】

Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine Hepatocytes In Vivo

机译:表面暴露的赖氨酸残基的定点诱变导致小鼠肝细胞体内的AAV2(而非AAV8)载体的转导提高

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The ubiquitin-proteasome pathway plays a critical role in the intracellular trafficking of recombinant adeno-associated virus 2 (AAV2) vectors, which negatively impacts the transduction efficiency of these vectors. Because ubiquitination occurs on lysine (K) residues, we performed site-directed mutagenesis where we replaced each of 10 surface-exposed K residues (K258, K490, K507, K527, K532, K544, K549, K556, K665, and K706) with glutamic acid (E) because of similarity of size and lack of recognition by modifying enzymes. The transduction efficiency of K490E, K544E, K549E, and K556E scAAV2 vectors increased in HeLa cells in vitro up to 5-fold compared with wild-type (WT) AAV2 vectors, with the K556E mutant being the most efficient. Intravenous delivery of WT and K-mutant ssAAV2 vectors further corroborated these results in murine hepatocytes in vivo. Because AAV8 vectors transduce murine hepatocytes exceedingly well, and because some of the surface-exposed K residues are conserved between these serotypes, we generated and tested two single mutants (K547E and K569E), and one double-mutant (K547+569E) AAV8 vector. However, no significant increase in the transduction efficiency of any of these mutant AAV8 vectors was observed in murine hepatocytes in vivo. These studies suggest that although targeting the surface-exposed K residues is yet another strategy to improve the transduction efficiency of AAV vectors, phenotypic outcome is serotype specific.
机译:泛素-蛋白酶体途径在重组腺相关病毒2(AAV2)载体的细胞内运输中起关键作用,这会对这些载体的转导效率产生负面影响。由于泛素化作用发生在赖氨酸(K)残基上,因此我们进行了定点诱变,我们用10个表面暴露的K残基(K258,K490,K507,K527,K532,K544,K549,K556,K665和K706)分别替换了谷氨酸(E),因为大小相似且缺乏通过修饰酶的识别。与野生型(WT)AAV2载体相比,K490E,K544E,K549E和K556E scAAV2载体在体外HeLa细胞中的转导效率提高了5倍,其中K556E突变体效率最高。 WT和K突变ssAAV2载体的静脉内递送进一步证实了体内小鼠肝细胞中的这些结果。由于AAV8载体能很好地转导鼠肝细胞,并且由于在这些血清型之间保留了一些表面暴露的K残基,因此我们生成并测试了两个单突变体(K547E和K569E)和一个双突变体(K547 + 569E)AAV8载体。然而,在体内小鼠肝细胞中未观察到任何这些突变的AAV8载体的转导效率的显着增加。这些研究表明,尽管靶向表面暴露的K残基是提高AAV载体转导效率的另一种策略,但表型结果是血清型特异性的。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号